• AT13387: Precision Hsp90 Inhibition for Translational Oncolo

  2026-06-20

  Explore how AT13387, a next-generation Hsp90 inhibitor, is redefining precision oncology by bridging mechanistic insight into chaperone inhibition, apoptosis induction, and strategic translational research. This thought-leadership article synthesizes evidence from cancer biology, regulated cell death, and recent advances in DAMP release to provide actionable guidance for translational teams aiming to accelerate bench-to-bedside progress.

• HBsAg–TBK1 Interaction Drives Immune Evasion and Early Autop

  2026-06-19

  This study uncovers a mechanism by which hepatitis B surface antigen (HBsAg) interacts directly with TANK-binding kinase 1 (TBK1), suppressing type I interferon signaling and inducing incomplete autophagy. These findings clarify how HBV evades innate immunity and highlight new therapeutic targets for chronic hepatitis B.

• AO/PI Double Staining Kit: Precision in Cell Viability Assay

  2026-06-19

  The AO/PI Double Staining Kit empowers researchers to accurately distinguish viable, apoptotic, and necrotic cells in complex samples. Its rapid dual-dye protocol streamlines cell viability and apoptosis detection, offering unmatched clarity and confidence for high-stakes applications like rare cell profiling and cancer subtyping.

• TMEM16F in Kupffer Cells: Safeguarding Liver from Listeria D

  2026-06-18

  This study uncovers the essential role of TMEM16F, a calcium-activated lipid scramblase, expressed specifically in liver Kupffer cells, in protecting against Listeria monocytogenes infection. The findings clarify the cell-type-specific mechanism by which TMEM16F prevents excessive inflammation and liver injury, with broader implications for understanding programmed necrotic cell death in infectious and inflammatory disease models.

• Gentamycin Sulfate in Bacterial Protein Synthesis Research

  2026-06-18

  Gentamycin Sulfate stands out as a gold-standard aminoglycoside antibiotic for dissecting ribosome function and resistance mechanisms in Gram-negative pathogens. This guide details optimized experimental workflows, troubleshooting tactics, and unique assay strategies that elevate reliability in antibiotic mechanism and resistance studies.

• Apigenin: Protocol Innovations for Cancer and Neuroprotectio

  2026-06-17

  Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) bridges oncology and neurodegeneration workflows with robust HDAC inhibition and multi-pathway modulation. Learn how APExBIO’s Apigenin enables streamlined setups, data-driven optimizations, and reliable troubleshooting for advanced cancer and Alzheimer’s disease models.

• NU7441 (KU-57788): Bridging DNA Repair Mechanisms to Oncolog

  2026-06-17

  This thought-leadership article explores how the selective DNA-PK inhibitor NU7441 (KU-57788) is advancing both DNA repair and oncology research. It spotlights mechanistic insights into DNA damage response, summarizes experimental findings, positions NU7441 within the translational research landscape, and provides strategic guidance for investigators in neuroinflammation and cancer. The article leverages recent studies on HIV-1-induced DNA repair vulnerability, contextualizes APExBIO's NU7441 as a uniquely potent tool, and outlines the next frontiers for precision medicine.

• LINC01550 Suppresses Colorectal Cancer via Wnt/β-Catenin Inh

  2026-06-16

  This study reveals that the long noncoding RNA LINC01550 is downregulated in colorectal cancer and acts as a tumor suppressor by inhibiting the Wnt/β-catenin pathway. The findings highlight LINC01550's potential as both a prognostic biomarker and a therapeutic target in colorectal cancer.

• Mavorixafor Hydrochloride: Redefining CXCR4 Antagonist Use i

  2026-06-16

  Explore how Mavorixafor hydrochloride (AMD-070 hydrochloride), a potent CXCR4 antagonist, is unlocking new frontiers in ischemia research and anti-HIV strategies. This article uniquely bridges CXCR4 signaling with tissue perfusion insights, providing advanced protocol guidance and practical assay considerations for biomedical scientists.

• GSH-Responsive MOF Nanoparticles Enhance Melanoma Therapy

  2026-06-15

  Hao et al. designed glutathione-responsive metal-organic framework (MOF) nanoparticles, loaded with indocyanine green (ICG) and modified with a PD-1 inhibitory peptide, for synergistic photothermal and immunotherapy in melanoma. This approach demonstrated targeted immune checkpoint blockade and potent tumor ablation, highlighting a promising direction for next-generation cancer nanomedicines.

• SHC-1 Inhibition Uncovers CFTR Trafficking Mechanisms in Epi

  2026-06-15

  Barros et al. systematically dissect how SHC-1 inhibition modulates the plasma membrane abundance of the CFTR chloride channel across distinct epithelial cell models. Their work clarifies conserved and context-dependent mechanisms of CFTR trafficking, informing both cystic fibrosis research and the design of secretory diarrhea assays.

• BnaMAPK1 Enhances Shading Tolerance in Rapeseed via Photosys

  2026-06-14

  This study uncovers how the mitogen-activated protein kinase BnaMAPK1 enhances shading tolerance in rapeseed by regulating photosystem II, specifically through interactions with light-harvesting complexes. These findings inform strategies for breeding stress-resilient Brassica napus and provide mechanistic insight into plant responses to low-light environments.

• Ceramide Metabolism Drives RGNNV Replication via Autophagy M

  2026-06-13

  This study elucidates how red-spotted grouper nervous necrosis virus (RGNNV) manipulates ceramide metabolism to facilitate viral replication in fish cells. By integrating global lipidomics and targeted functional assays, the authors identify ceramides—especially C16-ceramide—as key pro-viral mediators that promote autophagy, offering new mechanistic insights for antiviral strategy development.

• PP 1 (Src Family Tyrosine Kinase Inhibitor): Precision Contr

  2026-06-12

  Explore how PP 1, a potent Src family tyrosine kinase inhibitor, enables unprecedented precision in dissecting immune and oncogenic signaling pathways. This article uniquely bridges advanced mechanistic insight with next-generation assay design, offering researchers actionable guidance grounded in recent machine learning breakthroughs.

• Practical Use of DiI (DiIC18(3)) Plasma Membrane Probe

  2026-06-12

  DiI (DiIC18(3)) enables selective, high-contrast plasma membrane labeling in live and fixed cells, providing robust orange-red fluorescence for applications such as neuronal tracing, cell migration assays, and membrane-specific analyses. It should not be used for aqueous protocols or exclusive intracellular organelle labeling, and strict attention to solvent compatibility and membrane integrity is required for optimal results.

16416 records 1/1095 page Next 12345 下5页 Last page